Resistance situation of clinically important infectious pathogens to fluoroquinolones (ciprofloxacin) in Central Europe;Resistenzsituation bei klinisch wichtigen infektionserregern gegenüber fluorchinolonen (ciprofloxacin) in mitteleuropa

Chemotherapie Journal, Supplement

Volumn 11, Issue 20, 2001, Pages 18-24

  Kresken, Michael ^a   Hafner, Dieter ^a  

^a Gesell fur Klin Mikrobiologische   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; INFECTION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STRAIN DIFFERENCE; TREATMENT INDICATION;

EID: 0035757986     PISSN: 09446486     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Trends in antibiotic utilization and bacterial resistance
2. Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin
3. Methoden zur empfindlichkeitsprüfung von bakteriellen krankheitserregern (außer mykobakterien) gegen chemotherapeutika
4. Risk factors for acqusition of urinary tract infection caused by ciprofloxacin resistant Escherichia coli
5. Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromized patients
6. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin
7. Prevalence of fluoroquinolone resistance in Europe
8. The Study Group Bacterial Resistance of the Paul-Ehrlich-Society for Chemotherapy: Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975-1995
9. Resistenzentwicklung bei staphylokokken und anderen grampositiven erregern gegenüber chemotherapeutika im mitteleuropäischen raum
10. Studiengruppe: Resistenzsituation bei klinisch wichtigen infektionserregern gegenüber chemotherapeutika in mitteleuropa. Ergebnisse einer multizentrischen studie der arbeitsgemeinschaft "resistenz" in der Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. aus dem Jahre 1998
11. Einteilung der fluorchinolone
12. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections
13. Ten-year survey of quinolone resistance in escherichia coli causing urinary tract infections
14. Outpatient use of erythromycin: Link to increased erythromycin resistance in group a streptococci
15. Änderung der empfindlichkeit von Escherichia coli isolaten gegenüber ciprofloxacin zwischen 1992 und 1996
16. Bakterielle resistenz gegenüber chinolonen (ciprofloxacin)